Search Count: 4
 |
Crystal Structure Of Sars-Cov-2 Main Protease With Narlaprevir
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.78 Å Release Date: 2020-09-23 Classification: VIRAL PROTEIN Ligands: NNA |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2020-09-23
Ligands: NNA
 |
Crystal Structure Of Sars-Cov-2 Main Protease (3Clpro/Mpro) In Complex With Covalent Inhibitor Narlaprevir
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.79 Å Release Date: 2020-09-09 Classification: VIRAL PROTEIN, HYDROLASE/INHIBITOR Ligands: NNA, DMS, NA |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2020-09-09
Ligands: NNA, DMS, NA
 |
Room-Temperature X-Ray Crystal Structure Of Sars-Cov-2 Main Protease In Complex With Narlaprevir
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.30 Å Release Date: 2020-07-22 Classification: VIRAL PROTEIN/HYDROLASE Ligands: NNA |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2020-07-22
Ligands: NNA
 |
Hcv Ns3-4A Protease Domain With Ketoamide Inhibitor Narlaprevir
Organism: Hepatitis c virus subtype 1a
Method: X-RAY DIFFRACTION Resolution:2.20 Å Release Date: 2011-01-19 Classification: VIRAL PROTEIN/INHIBITOR Ligands: ZN, NNA, BME |
Organism: Hepatitis c virus subtype 1a
Method: X-RAY DIFFRACTION
Release Date: 2011-01-19
Ligands: ZN, NNA, BME